About Matthias Samwer
Matthias Samwer is a director at Cloverleaf Bio.
Experience
This experience comes from Matthias Samwer's profile and from SEC filings. For roles taken from filings, the years are when the filings name Matthias Samwer in the role, so the role may have started earlier or lasted longer.
Cloverleaf Bio, Inc. Current
Director Board of Directors
2026 – Present · New Haven, CT
Develops RNA-based cancer treatments for people with cancer.
AR
ArrePath Current
Director Board of Directors
2026 – Present
BI
Boehringer Ingelheim Current
Director, Corporate Venture Capital
2017 – Present
KC
Keck School of Medicine of the University of Southern California
Visiting Scientist
2023
2G
21Dx GmbH
Scientific Advisor
2021 – 2022
MS
Max Planck Institute for Multidisciplinary Sciences
Research Associate
2011 – 2013
Key Colleagues at Startups
The people Matthias Samwer works with at each company, as listed on that company's latest Form D.
Cloverleaf Bio, Inc. · Form D, Sep 9, 2026
CV
Christina Vorvis
Director
DK
Dima Kuzmin
Director
CL
Cole Lewis
Executive officer
AD
Austin Draycott
President and director